Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.4321 per EA under NDC 00832058111. Its NADAC has been published 401 times since Jan 30, 2019.
FDA first approved this application on Oct 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832058111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA209687FDA Approved
10/22/2018
TE Code
AB
On Market Since
10/22/2018
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 401 times since Jan 30, 2019, and over the history we have for it it has declined 76.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4321 per EA |
|---|---|
| All-time high | $1.8320 (Feb 13, 2019) |
| All-time low | $0.3902 (Aug 19, 2026) |
| 52-week high | $0.5144 |
| 52-week low | $0.3902 |
| Median price | $0.7032 |
| Average price | $0.7349 |
| Largest weekly change | +78.0% (Aug 23, 2023) |
| Weeks tracked | 401 |
| Tracking since | Jan 30, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobazam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.4321 per EA (NDC 00832058111), effective Sep 30, 2026.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 76.4%. It has been tracked across 401 weekly CMS publications since Jan 30, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since Jan 30, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.3902 (Aug 19, 2026) to a high of $1.8320 (Feb 13, 2019), with a median of $0.7032 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 00832058111) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.